What triggered Core Scientific shares' latest price surge

Traders Union
All News
Financial News
Core scientific rises 2.44% today

Highlights

Jericho Capital Asset Management acquired 11,699,823 shares of Core Scientific in Q3, signaling significant institutional interest.
The transaction, reported in SEC filings, boosts Core Scientific's profile among large-scale investors amid public market scrutiny.
Technicals show CORZ consolidating between $15.78 and $17.26, with mixed momentum signals and an 80%+ probability of an upward move next week.

Institutional stake builds as Jericho Capital increases holdings

Jericho Capital Asset Management L.P. disclosed the acquisition of 11,699,823 shares of Core Scientific in the third quarter, representing a notable institutional investment in the company. This move by Jericho Capital is reported through official SEC filings and pertains directly to Core Scientific’s publicly listed stock.

Anton Kharitonov, expert at Traders Union, sees little evidence of sustainable momentum in Core Scientific Inc. He notes that the price trades above its MA-20, but persistent resistance near the MA-50 remains a warning sign. The mixed oscillator and momentum signals imply weak conviction from buyers. Kharitonov is particularly cautious about the lack of confirmation by trend indicators despite the recent institutional inflow. "Without true technical strength and more balanced signals, I do not see justification for aggressive bullish positioning here," he says.

Viktoras Karapetjanc, expert at Traders Union, emphasizes that Core Scientific benefits from pronounced institutional interest, notably the Jericho Capital acquisition. He believes such strong participation points to growing confidence in the underlying business. Karapetjanc expects further growth as the long-term base remains stable and the price approaches key resistance levels. "Institutional inflows and constructive price action confirm that the bullish structure remains intact, so further upward extension looks likely," he states.

Mixed momentum signals as price tests resistance boundaries

At $16.89, CORZ is positioned above the MA-20 ($16.69) but remains below the MA-50 ($17.25), indicating modest short-term support while medium-term sellers still exert pressure. The MA-200 level at $15.95 suggests a robust long-term base, while the nearest dynamic support and resistance on the Ichimoku chart are seen at $16.73 (support) and $17.25 (resistance), respectively. Momentum signals are mixed, with the D1 MACD at "Strong Sell" and a neutral ADX reading, suggesting lackluster trend strength. Oscillator readings are also split: RSI signals "Sell", Stoch RSI is neutral but near overbought, and CCI reads neutral, while BBP points to an overbought intraday setup favoring buyers. The AO is neutral and does not confirm the daily upward move. Today's price shows a gap up at the open, gaining 2.44% so far, with the price now near the upper end of today's range ($17.10 high). Intraday volatility appears moderate, and price action points to strength toward session highs despite divergence between momentum and oscillator signals.

Earlier, analysts noted that Core Scientific was experiencing mixed momentum as it balanced short-term selling pressure with longer-term technical support. The current presence of strong institutional buying, combined with emerging bullish intraday price action, underscores a constructive shift, making a break above $17.25 the pivotal level to watch for potential further upside.

Source of Data: CORZ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.